BERTAGNIN, CHIARA

BERTAGNIN, CHIARA  

Dipartimento di Medicina Molecolare - DMM  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant 2018 BERTAGNIN, CHIARALoregian, Arianna + JOURNAL OF MEDICINAL CHEMISTRY - -
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 2018 Messa, LorenzoCelegato, MartaBertagnin, ChiaraMercorelli, BeatriceNannetti, GiulioPalù, GiorgioLoregian, Arianna SCIENTIFIC REPORTS - -
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant 2018 Bertagnin, ChiaraLoregian, Arianna + JOURNAL OF MEDICINAL CHEMISTRY - -
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 2019 Nannetti, GiulioMercorelli, BeatriceBertagnin, ChiaraPalù, GiorgioLoregian, Arianna + ANTIVIRAL RESEARCH - -
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 2020 Celegato M.Messa L.Mercorelli B.Bertagnin C.Palu G.Loregian A. + CANCER LETTERS - -
Identification of C5-NH2 Modified Oseltamivir Derivatives as Novel Influenza Neuraminidase Inhibitors with Highly Improved Antiviral Activities and Favorable Druggability 2021 Bertagnin C.Loregian A. + JOURNAL OF MEDICINAL CHEMISTRY - -
Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity 2021 Bertagnin C.Loregian A. + EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - -
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib 2021 Messa L.Celegato M.Bertagnin C.Mercorelli B.Alvisi G.Palu G.Loregian A. + CANCERS - -
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors 2021 Bertagnin C.Bonomini A.Loregian A. + EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - -
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase 2021 Bertagnin C.Nannetti G.Loregian A. + EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - -
Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity 2022 Bonomini, AnnaBertagnin, ChiaraLoregian, Arianna + JOURNAL OF MEDICINAL CHEMISTRY - -
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 2022 Celegato M.Messa L.Bertagnin C.Mercorelli B.Loregian A. CANCERS - -